These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32073738)

  • 1. Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10.
    Farrow GS; Delate T; McNeil K; Jones AE; Witt DM; Crowther MA; Clark NP
    J Thromb Haemost; 2020 May; 18(5):1133-1140. PubMed ID: 32073738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
    Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
    J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.
    Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA
    J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Supratherapeutic International Normalized Ratio without Bleeding after Warfarin Use: An Evaluation of Vitamin K Administration (SUPRA-WAR-K Study).
    Tai C; Wu H; San C; Chua D
    Can J Hosp Pharm; 2017; 70(3):207-214. PubMed ID: 28680174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement.
    Yu HY; Liu CH; Chen YS; Wang SS; Chu SH; Lin FY
    J Formos Med Assoc; 2005 Apr; 104(4):236-43. PubMed ID: 15909060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
    Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
    Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
    Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
    Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage.
    Cicci CD; Weiss A; Dang C; Stanton M; Feldman R
    Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.
    Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C
    J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.